Axonics Inc (AXNX)
67.28
+0.17
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
67.24
-0.04
(-0.06%)
After-Hours: 20:00
Axonics Cash from Operations (TTM): -10.47M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -10.47M |
December 31, 2023 | -2.016M |
September 30, 2023 | 1.707M |
June 30, 2023 | -6.79M |
March 31, 2023 | 11.58M |
December 31, 2022 | 3.191M |
September 30, 2022 | -12.94M |
June 30, 2022 | -19.78M |
March 31, 2022 | -30.89M |
December 31, 2021 | -47.31M |
September 30, 2021 | -68.84M |
Date | Value |
---|---|
June 30, 2021 | -85.00M |
March 31, 2021 | -86.02M |
December 31, 2020 | -83.74M |
September 30, 2020 | -83.56M |
June 30, 2020 | -88.32M |
March 31, 2020 | -93.71M |
December 31, 2019 | -83.45M |
September 30, 2019 | -64.61M |
June 30, 2019 | -48.81M |
March 31, 2019 | -37.81M |
December 31, 2018 | -31.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-93.71M
Minimum
Mar 2020
11.58M
Maximum
Mar 2023
-44.99M
Average
-48.06M
Median
Cash from Operations (TTM) Benchmarks
Boston Scientific Corp | 2.477B |
Cutera Inc | -137.64M |
Stereotaxis Inc | -9.139M |
Electromed Inc | 4.872M |
Myomo Inc | -6.173M |